Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.292
-0.005 (-1.75%)
At close: Nov 4, 2024, 4:00 PM
0.291
-0.001 (-0.45%)
After-hours: Nov 4, 2024, 7:19 PM EST

Cara Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
8.6820.2741.8723.03135.0819.89
Upgrade
Other Revenue
2.310.7----
Upgrade
Revenue
1120.9741.8723.03135.0819.89
Upgrade
Revenue Growth (YoY)
-59.53%-49.92%81.81%-82.95%579.28%47.64%
Upgrade
Cost of Revenue
88.85113.5598.0181.56107.07113.16
Upgrade
Gross Profit
-77.85-92.58-56.14-58.5428.01-93.28
Upgrade
Selling, General & Admin
27.1428.9231.3930.5522.6318.4
Upgrade
Operating Expenses
27.1428.9231.3930.5522.6318.4
Upgrade
Operating Income
-104.98-121.5-87.54-89.085.39-111.68
Upgrade
Interest Expense
-4.5-0.6----
Upgrade
Other Non Operating Income (Expenses)
2.493.192.331.392.223.11
Upgrade
EBT Excluding Unusual Items
-106.99-118.91-85.21-87.697.6-108.57
Upgrade
Gain (Loss) on Sale of Investments
0.890.4-0.26-0.820.121.38
Upgrade
Gain (Loss) on Sale of Assets
---0.07--
Upgrade
Pretax Income
-111.08-118.51-85.47-88.447.72-107.19
Upgrade
Income Tax Expense
-----0.69-0.82
Upgrade
Net Income
-111.08-118.51-85.47-88.448.41-106.37
Upgrade
Net Income to Common
-111.08-118.51-85.47-88.448.41-106.37
Upgrade
Shares Outstanding (Basic)
555454514743
Upgrade
Shares Outstanding (Diluted)
555454514843
Upgrade
Shares Change (YoY)
1.24%0.92%5.79%5.85%12.29%18.88%
Upgrade
EPS (Basic)
-2.04-2.19-1.59-1.740.18-2.49
Upgrade
EPS (Diluted)
-2.04-2.19-1.59-1.740.18-2.49
Upgrade
Free Cash Flow
-83.33-94.45-78.77-60.13-5.84-109.24
Upgrade
Free Cash Flow Per Share
-1.53-1.74-1.47-1.19-0.12-2.56
Upgrade
Gross Margin
---134.09%-254.19%20.74%-
Upgrade
Operating Margin
-954.75%-579.43%-209.08%-386.85%3.99%-561.60%
Upgrade
Profit Margin
-1010.19%-565.21%-204.16%-384.06%6.23%-534.91%
Upgrade
Free Cash Flow Margin
-757.78%-450.46%-188.15%-261.10%-4.32%-549.35%
Upgrade
EBITDA
-104.72-121.24-87.29-88.845.59-111.48
Upgrade
EBITDA Margin
---208.49%-4.14%-
Upgrade
D&A For EBITDA
0.260.260.250.250.210.2
Upgrade
EBIT
-104.98-121.5-87.54-89.085.39-111.68
Upgrade
EBIT Margin
---209.08%-3.99%-
Upgrade
Revenue as Reported
1120.9741.8723.03135.0819.89
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.